Blood-Brain Glucose Transfer in Alzheimer’s disease: Effect of GLP-1 Analog Treatment

por Gejl, Michael, Brock, Birgitte, Egefjord, Lærke, Vang, Kim, Rungby, Jørgen, Gjedde, Albert
Publicado 2017

Glucagon-like peptide-1 (GLP-1) raises blood-brain glucose transfer capacity and hexokinase activity in human brain

por Gejl, Michael, Lerche, Susanne, Egefjord, Lærke, Brock, Birgitte, Møller, Niels, Vang, Kim, Rodell, Anders B., Bibby, Bo M., Holst, Jens J., Rungby, Jørgen, Gjedde, Albert
Publicado 2013

In Alzheimer’s Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial

por Gejl, Michael, Gjedde, Albert, Egefjord, Lærke, Møller, Arne, Hansen, Søren B., Vang, Kim, Rodell, Anders, Brændgaard, Hans, Gottrup, Hanne, Schacht, Anna, Møller, Niels, Brock, Birgitte, Rungby, Jørgen
Publicado 2016

Zinc transporter gene expression is regulated by pro-inflammatory cytokines: a potential role for zinc transporters in beta-cell apoptosis?

por Egefjord, Lærke, Jensen, Jens Ledet, Bang-Berthelsen, Claus Heiner, Petersen, Andreas Brønden, Smidt, Kamille, Schmitz, Ole, Karlsen, Allan Ertman, Pociot, Flemming, Chimienti, Fabrice, Rungby, Jørgen, Magnusson, Nils E
Publicado 2009